ArticleThe Journal of investigative dermatology2008
Tumor evasion may occur via expression of regulatory molecules: a case for CTLA-4 in melanoma.
Article in The Journal of investigative dermatology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 10 citations in OpenAlex.
- Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma.Journal of cancer research and clinical oncology · 2023Article
- Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020Review
- Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4.Cancer research · 2018Article
- Novel anti-melanoma immunotherapies: disarming tumor escape mechanisms.Clinical & developmental immunology · 2012Review
- Interface of signal transduction inhibition and immunotherapy in melanoma.Cancer journal (Sudbury, Mass.)Review
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging data that show immune-regulating molecules may be ectopically expressed on human tumors suggest that novel mechanisms may induce tumor-related immune suppression, and support the use of antibodies and small molecules to target those immune-suppressive moities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.